Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
591 trials across Europe, recruiting first
Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant
BelgiumStudy on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer
CzechiaStudy of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy
FranceStudy on the Effects of Vonafexor, Rosuvastatin Zinc, and Iohexol on Kidney Function in Patients with Impaired Renal Function and Suspected MASH
GermanyStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
AustriaStudy of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
FranceStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
AustriaStudy on the Safety and Effectiveness of Erdafitinib Alone or with Cetrelimab and Chemotherapy for Patients with Metastatic or Advanced Urothelial Cancer
SpainStudy of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery
FranceStudy on Durvalumab with Trimodality Therapy for Patients with Muscle-Invasive Bladder Cancer
SpainStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
BelgiumStudy Comparing Erdafitinib with Vinflunine, Docetaxel, or Pembrolizumab for Patients with Advanced Urothelial Cancer and FGFR Gene Changes
BelgiumThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
